Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Queensland Health
Julphar
Baxter
Express Scripts
QuintilesIMS
Mallinckrodt
Novartis
US Army
Farmers Insurance

Generated: August 16, 2017

DrugPatentWatch Database Preview

SONATA Drug Profile

« Back to Dashboard

Which patents cover Sonata, and when can generic versions of Sonata launch?

Sonata is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in SONATA is zaleplon. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the zaleplon profile page.

Summary for Tradename: SONATA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list6
Bulk Api Vendors: see list51
Clinical Trials: see list8
Patent Applications: see list1,829
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SONATA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
SONATA
zaleplon
CAPSULE;ORAL020859-001Aug 13, 1999ABRXYesNo► Subscribe► Subscribe► Subscribe
Pfizer
SONATA
zaleplon
CAPSULE;ORAL020859-002Aug 13, 1999ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SONATA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
SONATA
zaleplon
CAPSULE;ORAL020859-001Aug 13, 1999► Subscribe► Subscribe
Pfizer
SONATA
zaleplon
CAPSULE;ORAL020859-002Aug 13, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: SONATA

Drugname Dosage Strength RLD Submissiondate
zaleplonCapsules5 mg and 10 mgSonata6/21/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Accenture
Boehringer Ingelheim
McKesson
Chubb
Medtronic
Healthtrust
Queensland Health
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot